The novel prandial insulin formulation from Eli Lilly is now approved for administration via continuous subcutaneous insulin infusion with an insulin pump.
COVID-19 patients with hyperglycemia on hospital admission, with and without diabetes, had increased odds of intubation, ICU admission, and mortality, according to research presented at ENDO 2021.
ENDO 2021: An investigational once-weekly insulin formulation was found as effective as daily basal insulin injection for glucose control with lower rates of hypoglycemia and less weight gain.
Insulin affordability is an ongoing discussion topic for patients with diabetes and their care providers. The already difficult issue has been further compounded by the ongoing COVID-19 pandemic.
Three patients with type 2 diabetes in different stages of life and disease all require insulin management for A1c control.
Insulin degludec vs glargine--which costs less per anum and why? We summarize this study and 2 other direct insulin comparisons reported at ADA 2017.
Stringent control was supported even in patients at high risk for related harm. Reasons found for concern over Rx "deintensification" may surprise you.
Here’s a look at what’s new and interesting on the Web for health care professionals.
Maintaining tight glycemic control in older diabetic adults who are in poor health can do far more harm than good, according to results of a new study.
Activation of opioid receptors with novel approaches may prevent hypoglycemia and lead to safer intensive glycemic control, according to a study reported at the American Diabetes Association 74th Scientific Sessions.